Does baricitinib reduce disease activity in patients with systemic lupus erythematosus? A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Does baricitinib reduce disease activity in patients with systemic lupus erythematosus? A systematic review and meta-analysis of randomized controlled trials

Published:2023-08-15 Issue:2 Volume:43 Page:579-589
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Amer Basma Ehab^ORCID,Afifi Eslam^ORCID,Mouffokes Adel^ORCID,Hamad Abdullah Ashraf^ORCID,Amin Ahmed Mostafa^ORCID,Abdelwahab Omar Ahmed^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s10067-023-06731-4.pdf

Reference46 articles.

1. Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, Van Vollenhoven R, Ruiz-Irastorza G, Hughes G (2016) Systemic lupus erythematosus. Nat Rev Dis Prim 2:1–22. https://doi.org/10.1038/nrdp.2016.39

2. Rao AP, Raghuram J (2016) Systemic lupus erythematosus. Indian J Pract Pediatr 18:313–319. https://doi.org/10.7326/aitc202006020

3. Tsokos G (2011) Systemic lupus erythematosus. N Engl J Med. https://doi.org/10.1056/NEJMra1100359

4. Yap DYH, Chan TM (2019) B cell abnormalities in systemic lupus erythematosus and lupus nephritis—role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci 20:1–18. https://doi.org/10.3390/ijms20246231

5. Wahren-Herlenius M, Dörner T (2013) Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382:819–831. https://doi.org/10.1016/S0140-6736(13)60954-X

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tofacitinib therapy in systemic lupus erythematosus with arthritis: a retrospective study;Clinical Rheumatology;2024-08-13

2. Outlook of the jakinibs in systemic lupus erythematous after baricitinib failed;International Journal of Rheumatic Diseases;2024-02